INS and Alzheimer disease: Due to impaired insulin metabolism in the brain in AD, nasally administered insulin and empagliflozin are also being examined [149] In the past, there have been varied results with intranasal insulin – some studies have shown improved memory and cognitive function while others have shown no improvement [149].